Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Agios Pharmaceuticals (AGIO) over the last 14 years, with Q4 2025 value amounting to 0.92.

  • Agios Pharmaceuticals' Equity Ratio fell 72.94% to 0.92 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.92, marking a year-over-year decrease of 72.94%. This contributed to the annual value of 0.92 for FY2025, which is 72.94% down from last year.
  • According to the latest figures from Q4 2025, Agios Pharmaceuticals' Equity Ratio is 0.92, which was down 72.94% from 0.93 recorded in Q3 2025.
  • Over the past 5 years, Agios Pharmaceuticals' Equity Ratio peaked at 0.94 during Q1 2025, and registered a low of 0.85 during Q2 2024.
  • Moreover, its 5-year median value for Equity Ratio was 0.9 (2022), whereas its average is 0.9.
  • Its Equity Ratio has fluctuated over the past 5 years, first surged by 9185.93% in 2021, then tumbled by 384.49% in 2024.
  • Agios Pharmaceuticals' Equity Ratio (Quarter) stood at 0.9 in 2021, then decreased by 1.11% to 0.89 in 2022, then fell by 2.61% to 0.87 in 2023, then increased by 7.06% to 0.93 in 2024, then fell by 0.73% to 0.92 in 2025.
  • Its Equity Ratio was 0.92 in Q4 2025, compared to 0.93 in Q3 2025 and 0.93 in Q2 2025.